NEU 0.72% $20.72 neuren pharmaceuticals limited

A De-risked bio-tech with 4X upside - Karst Peak Capital, page-9

  1. 1,173 Posts.
    lightbulb Created with Sketch. 303
    in the report they indicated that they added to their position post result announcement. Milford has done the same by buying more on market given the strength of the results. Two of NEU’s key institutional backers double down on their investment post phase 3 results - what does it tell you?

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.